Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00241 ALI HEALTH
RTNominal down21.950 -0.050 (-0.227%)
Research Report

21/01/2021 15:28

{I-bank focus}Daiwa starts Alibaba Health (00241) at HK$32.8

[ET Net News Agency, 21 January 2021] Daiwa Research initiated coverage on Alibaba
Health Information Technology (ALH) (00241) with a "buy" rating and a target price of
HK$32.8.
The research house sees ALH as one of the early-movers among China's HealthTech digital
new infrastructure creators with a unique presence in some niche areas.
Daiwa said ALH, 68% jointly owned by Alibaba (09988), YF Capital and Ant Group, also
benefits from Alibaba Group's ecosystems, including (1) access to retail user traffic from
China's leading online shopping portals (Tmall and Taobao) and FinTech gateway (Alipay),
(2) leveraging the service capacity of partners under Alibaba's ecosystem, such as payment
services supported by Ant Group, and fast-drug-delivery services enabled by Ele.me and
Koubei, and (3) enjoying its ecosystem partners' strong technology capabilities in cloud
computing, Big Data and AI to offer participants with intelligent digital solutions. (KL)

Remark: Real time quote last updated: 13/04/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.